Back
Axsome Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
AXSM
Axsome Therapeutics
Last Price:
$107.54
Seasonality Move:
-0.67%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.
Axsome Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.72 | Sell |
20-day SMA: | 108.35 | Sell |
50-day SMA: | 111.74 | Sell |
200-day SMA: | 99.85 | Buy |
8-day EMA: | 107.68 | Sell |
20-day EMA: | 108.32 | Sell |
50-day EMA: | 109.71 | Sell |
200-day EMA: | 101.18 | Buy |
Axsome Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.68 | Sell |
Relative Strength Index (14 RSI): | 47.79 | Sell |
Chaikin Money Flow: | -85976 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.25 - 111.25) | Buy |
Bollinger Bands (100): | (94.31 - 123.25) | Sell |
Axsome Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 107.53 while AXSM 8-day simple moving average is 107.72, which is a Sell signal.
-
The stock price of AXSM is 107.53 while Axsome Therapeutics 20-day SMA is 108.35, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 111.74 while AXSM share price is 107.53, making it a Sell technically.
-
AXSM stock price is 107.53 and Axsome Therapeutics 200-day simple moving average is 99.85, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
37
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $107.53. The Score for AXSM is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.3B
Price in USD:
107.53
Share Volume:
627.9K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
37
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 107.53 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 107.53 while AXSM 8-day exponential moving average is 107.68, which is a Sell signal.
-
The stock price of AXSM is 107.53 while Axsome Therapeutics 20-day EMA is 108.32, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 109.71 while AXSM share price is 107.53, making it a Sell technically.
-
AXSM stock price is 107.53 and Axsome Therapeutics 200-day simple moving average is 101.18, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.90 per share, an increase this year of $1.51 per share, and an increase next year of $4.87 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 47.79, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (103.25 - 111.25), which suggest Axsome Therapeutics is a Sell
-
The Bollinger Bands (100) for Axsome Therapeutics is (94.31 - 123.25), which suggest Axsome Therapeutics is a Sell
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.